A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the Face
Clinical trial NCT05210582 · UNKNOWN
Trial details
- NCT number
- NCT05210582
- Sponsor
- Clinuvel, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-11
- Primary completion
- 2023-04-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.